5-(biotinamido)pentylamine has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, J; Ding, K; Gao, F; Liang, Y; Wang, Y; Zhou, P | 1 |
1 other study(ies) available for 5-(biotinamido)pentylamine and Ovarian Neoplasms
Article | Year |
---|---|
Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Endometrioid; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Female; G2 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Katanin; Ligands; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Molecular Structure; Ovarian Neoplasms; Pyridines; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays | 2019 |